Free Trial

Arrowstreet Capital Limited Partnership Acquires Shares of 193,096 Viemed Healthcare, Inc. (NASDAQ:VMD)

Viemed Healthcare logo with Medical background
Remove Ads

Arrowstreet Capital Limited Partnership acquired a new position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 193,096 shares of the company's stock, valued at approximately $1,549,000. Arrowstreet Capital Limited Partnership owned 0.50% of Viemed Healthcare as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in VMD. National Bank of Canada FI lifted its holdings in Viemed Healthcare by 91.2% during the third quarter. National Bank of Canada FI now owns 3,346 shares of the company's stock valued at $25,000 after purchasing an additional 1,596 shares in the last quarter. R Squared Ltd purchased a new position in shares of Viemed Healthcare during the 4th quarter valued at $41,000. Walleye Capital LLC bought a new position in Viemed Healthcare in the 3rd quarter worth $87,000. EntryPoint Capital LLC purchased a new stake in Viemed Healthcare in the 4th quarter worth $92,000. Finally, Prudential Financial Inc. bought a new stake in Viemed Healthcare during the fourth quarter valued at about $93,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD traded up $0.02 during mid-day trading on Tuesday, reaching $6.61. The company's stock had a trading volume of 48,432 shares, compared to its average volume of 136,841. The stock has a fifty day moving average of $7.44 and a two-hundred day moving average of $8.14. The firm has a market capitalization of $261.24 million, a PE ratio of 24.48 and a beta of 1.64. Viemed Healthcare, Inc. has a 52 week low of $6.21 and a 52 week high of $9.81. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Remove Ads

Viemed Healthcare Company Profile

(Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Further Reading

Institutional Ownership by Quarter for Viemed Healthcare (NASDAQ:VMD)

Should You Invest $1,000 in Viemed Healthcare Right Now?

Before you consider Viemed Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.

While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads